Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications

Introduction: There are increasing concerns world-wide with growing rates of antibiotic resistance necessitating urgent action. There have been a number of initiatives in the Republic of Srpska in recent years to address this and improve rational antibiotic prescribing and dispensing despite limited...

Full description

Bibliographic Details
Main Authors: Ljubica Bojanić, Vanda Marković-Peković, Ranko Škrbić, Nataša Stojaković, Mirjana Ðermanović, Janja Bojanić, Jurij Fürst, Amanj B. Kurdi, Brian Godman
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.00442/full
id doaj-55bf5d466d254d14b16f69e4d1ef1c96
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Ljubica Bojanić
Ljubica Bojanić
Vanda Marković-Peković
Vanda Marković-Peković
Ranko Škrbić
Nataša Stojaković
Mirjana Ðermanović
Mirjana Ðermanović
Janja Bojanić
Janja Bojanić
Jurij Fürst
Amanj B. Kurdi
Amanj B. Kurdi
Brian Godman
Brian Godman
Brian Godman
Brian Godman
spellingShingle Ljubica Bojanić
Ljubica Bojanić
Vanda Marković-Peković
Vanda Marković-Peković
Ranko Škrbić
Nataša Stojaković
Mirjana Ðermanović
Mirjana Ðermanović
Janja Bojanić
Janja Bojanić
Jurij Fürst
Amanj B. Kurdi
Amanj B. Kurdi
Brian Godman
Brian Godman
Brian Godman
Brian Godman
Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications
Frontiers in Pharmacology
antibiotic utilization
antibiotic resistance
cross national comparative study
initiatives
Republic of Srpska
quality indicators
author_facet Ljubica Bojanić
Ljubica Bojanić
Vanda Marković-Peković
Vanda Marković-Peković
Ranko Škrbić
Nataša Stojaković
Mirjana Ðermanović
Mirjana Ðermanović
Janja Bojanić
Janja Bojanić
Jurij Fürst
Amanj B. Kurdi
Amanj B. Kurdi
Brian Godman
Brian Godman
Brian Godman
Brian Godman
author_sort Ljubica Bojanić
title Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications
title_short Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications
title_full Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications
title_fullStr Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications
title_full_unstemmed Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications
title_sort recent initiatives in the republic of srpska to enhance appropriate use of antibiotics in ambulatory care; their influence and implications
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2018-05-01
description Introduction: There are increasing concerns world-wide with growing rates of antibiotic resistance necessitating urgent action. There have been a number of initiatives in the Republic of Srpska in recent years to address this and improve rational antibiotic prescribing and dispensing despite limited resources to fund multiple initiatives.Objective: Analyse antibiotic utilization patterns in the Republic of Srpska following these multiple initiatives as a basis for developing future programmes in the Republic if needed.Methods: Observational retrospective study of total outpatient antibiotic utilization from 2010 to 2015, based on data obtained from the Public Health Institute, alongside documentation of ongoing initiatives to influence utilization. The quality of antibiotic utilization principally assessed according to ESAC, ECDC, and WHO quality indicators and DU 90% (the drug utilization 90%) profile as well as vs. neighboring countries.Results: Following multiple initiatives, antibiotic utilization remained relatively stable in the Republic at 15.6 to 18.4 DIDs, with a decreasing trend in recent years, with rates comparable or lower than neighboring countries. Amoxicillin and the penicillins accounted for 29–40 and 50% of total utilization, respectively. Overall, limited utilization of co-amoxiclav (7–11%), cephalosporins, macrolides, and quinolones, as well as low use of third and fourth generation cephalosporins vs. first and second cephalosporins. However, increasing utilization of co-amoxiclav and azithromycin, as well as higher rates of quinolone utilization compared to some countries, was seen.Conclusions: Multiple interventions in the Republic of Srpska in recent years have resulted in one of the lowest utilization of antibiotics when compared with similar countries, acting as an exemplar to others. However, there are some concerns with current utilization of co-amoxiclav and azithromycin which are being addressed. This will be the subject of future research activities.
topic antibiotic utilization
antibiotic resistance
cross national comparative study
initiatives
Republic of Srpska
quality indicators
url https://www.frontiersin.org/article/10.3389/fphar.2018.00442/full
work_keys_str_mv AT ljubicabojanic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT ljubicabojanic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT vandamarkovicpekovic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT vandamarkovicpekovic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT rankoskrbic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT natasastojakovic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT mirjanaðermanovic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT mirjanaðermanovic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT janjabojanic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT janjabojanic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT jurijfurst recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT amanjbkurdi recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT amanjbkurdi recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT briangodman recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT briangodman recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT briangodman recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
AT briangodman recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications
_version_ 1725943787156406272
spelling doaj-55bf5d466d254d14b16f69e4d1ef1c962020-11-24T21:35:49ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-05-01910.3389/fphar.2018.00442372014Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and ImplicationsLjubica Bojanić0Ljubica Bojanić1Vanda Marković-Peković2Vanda Marković-Peković3Ranko Škrbić4Nataša Stojaković5Mirjana Ðermanović6Mirjana Ðermanović7Janja Bojanić8Janja Bojanić9Jurij Fürst10Amanj B. Kurdi11Amanj B. Kurdi12Brian Godman13Brian Godman14Brian Godman15Brian Godman16Public Health Institute, Banja Luka, Bosnia and HerzegovinaDepartment of Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and HerzegovinaMinistry of Health and Social Welfare, Banja Luka, Bosnia and HerzegovinaDepartment of Social Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and HerzegovinaDepartment of Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and HerzegovinaDepartment of Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and HerzegovinaPublic Health Institute, Banja Luka, Bosnia and HerzegovinaDepartment of Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and HerzegovinaPublic Health Institute, Banja Luka, Bosnia and HerzegovinaDepartment of Epidemiology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and HerzegovinaHealth Insurance Institute of Slovenia, Ljubljana, SloveniaStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United KingdomDepartment of pharmacology and toxicology, College of Pharmacy, Hawler Medical University, Erbil, IraqStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom0Liverpool Health Economics Centre, Liverpool University, Liverpool, United Kingdom1Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden2School of Pharmaceutical Sciences, Universiti Sains Malaysia, Kota Bharu, MalaysiaIntroduction: There are increasing concerns world-wide with growing rates of antibiotic resistance necessitating urgent action. There have been a number of initiatives in the Republic of Srpska in recent years to address this and improve rational antibiotic prescribing and dispensing despite limited resources to fund multiple initiatives.Objective: Analyse antibiotic utilization patterns in the Republic of Srpska following these multiple initiatives as a basis for developing future programmes in the Republic if needed.Methods: Observational retrospective study of total outpatient antibiotic utilization from 2010 to 2015, based on data obtained from the Public Health Institute, alongside documentation of ongoing initiatives to influence utilization. The quality of antibiotic utilization principally assessed according to ESAC, ECDC, and WHO quality indicators and DU 90% (the drug utilization 90%) profile as well as vs. neighboring countries.Results: Following multiple initiatives, antibiotic utilization remained relatively stable in the Republic at 15.6 to 18.4 DIDs, with a decreasing trend in recent years, with rates comparable or lower than neighboring countries. Amoxicillin and the penicillins accounted for 29–40 and 50% of total utilization, respectively. Overall, limited utilization of co-amoxiclav (7–11%), cephalosporins, macrolides, and quinolones, as well as low use of third and fourth generation cephalosporins vs. first and second cephalosporins. However, increasing utilization of co-amoxiclav and azithromycin, as well as higher rates of quinolone utilization compared to some countries, was seen.Conclusions: Multiple interventions in the Republic of Srpska in recent years have resulted in one of the lowest utilization of antibiotics when compared with similar countries, acting as an exemplar to others. However, there are some concerns with current utilization of co-amoxiclav and azithromycin which are being addressed. This will be the subject of future research activities.https://www.frontiersin.org/article/10.3389/fphar.2018.00442/fullantibiotic utilizationantibiotic resistancecross national comparative studyinitiativesRepublic of Srpskaquality indicators